Hospitals are facing increasingly burdensome policies from commercial insurers, leading to problems with cash flow and patient safety. Hospital executives think federal regulators need to enact stricter policies that require payers to operate on faster timelines, as well as provide more transparency into their reasons for denying claims.
Zach Klaassen and Neal Shore discuss the outcomes of the EMBARK trial, focusing on treatment strategies for high-risk biochemically recurrent prostate cancer. In this detailed…
Sanofi is the third company – along with J&J and Eli Lilly – to attempt to change the way it pays for medicines under the…
Seen Health emerged from stealth on Monday. The company builds on the Program of All-Inclusive Care for the Elderly model and focuses on Asian and…
David Crawford discusses with Daniel Petrylak a new approach to treating advanced prostate cancer using a PROTAC agent called ARV-766. Dr. Petrylak explains that PROTACs…
Thursday, December 5, 2024 Thursday, December 12, 2024 Thursday, December 19, 2024 Credit Type CME,CNE,AAPA, AANP Intended Learners This activity is intended for primary care…
Zach Klaassen discusses the ARASTEP trial with Alex Chehrazi-Raffle. The trial focuses on patients with high-risk biochemical recurrence of prostate cancer, specifically those who show…
During a recent panel discussion, three healthcare experts discussed reasons why value-based care is struggling to reach scale.
Sam Chang interviews Surena Matin about a phase 1b trial evaluating FGFR3 inhibition in localized upper tract urothelial carcinoma (UTUC). Dr. Matin discusses the study’s…
The U.S. Centers for Disease Control and Prevention (CDC) said on Friday it has confirmed a human infection with H5N1 bird flu in a child…
